ArticleAntimicrobial agents and chemotherapy2018

GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants.

Nicole S Delino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.